Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-008145
Filing Date
2019-02-14
Accepted
2019-02-14 16:34:03
Documents
1
Group Members
SHIRAT HACHAIM LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv513407_sc13ga.htm SC 13G/A 76059
  Complete submission text file 0001144204-19-008145.txt   77392
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Subject) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88495 | Film No.: 19607169
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALMED PHARMACEUTICALS LTD., 8 SHAUL HAMELECH BLVD, AMOT HAMISHPAT BLDG. TEL AVIV L3 64733
Business Address
Hurvitz Chaim (Filed by) CIK: 0001630542 (see all company filings)

Type: SC 13G/A